{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:00:03Z","timestamp":1793624403015,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Frequent self-monitoring of blood glucose (SMBG) is the only accurate method available for insulin dose titration in patients with T1DM. Professional continuous glucose monitoring (p-CGM) is blinded recording of glucose trends over 5\u20137 days and helps physicians to guide insulin titration to patient. This study was planned to assess efficacy of insulin dose adjustments, based on\u00a0p-CGM plus SMBG in improving glycemic control compared to SMBG alone. We did an open-label, parallel design, randomized control trial among children (2\u201310 years) having T1DM for at least 6 months. Subjects in the<jats:italic>intervention group<\/jats:italic>were placed on p-CGM (iPRO 2\u2122 Professional CGM, Medtronic, USA) for 3\u20135 days along with regular SMBG. Data from p-CGM was analyzed by physician and used to guide insulin titration along with SMBG over following 3 months.<jats:italic>Control group<\/jats:italic>had only SMBG records for titrating insulin doses. Primary outcome was change in HbA1c 3 months after intervention. A total of 68 eligible children were randomized, 34 each to either arms. Thirty children in intervention group and 33 in control group completed the study and were analyzed. It was found that there was more decreased unit change in HbA1c, percentage of low sugar records and total insulin requirement per day, after 3 months follow-up, in intervention group. However, difference was not significant except for total insulin Units\/kg\/day (p\u2009=\u20090.014). In sub-group analysis of children with baseline HbA1c &gt;7.5%, there was a significant mean fall of HbA1c by 1.27% (p\u2009=\u20090.045). There were no major adverse events associated with p-CGM. We conclude that addition of p-CGM along with SMBG may help in adjusting insulin dose more effectively especially in children with higher baseline HbA1c.<\/jats:p>","DOI":"10.1038\/s41598-019-42555-6","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T10:03:21Z","timestamp":1555409001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial"],"prefix":"10.1038","volume":"9","author":[{"given":"K. V.","family":"Raviteja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0039-2142","authenticated-orcid":false,"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devi","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"issue":"14","key":"42555_CR1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DM Nathan","year":"1993","unstructured":"Diabetes Control and Complications Trial Research Group, Nathan, D. M. et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus. N Engl J Med. 329(14), 977\u201386 (1993).","journal-title":"N Engl J Med."},{"key":"42555_CR2","doi-asserted-by":"crossref","unstructured":"Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J. Pediatr. 125, 177\u2013188 (1994).","DOI":"10.1016\/S0022-3476(94)70190-3"},{"issue":"11","key":"42555_CR3","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.2337\/diacare.24.11.1858","volume":"24","author":"E Boland","year":"2001","unstructured":"Boland, E. et al. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type1 diabetes. Diabetes. Care. 24(11), 1858\u201362 (2001).","journal-title":"Diabetes. Care."},{"issue":"7","key":"42555_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1089\/dia.2010.0021","volume":"12","author":"HP Chase","year":"2010","unstructured":"Chase, H. P. et al. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technol Ther. 12(7), 507\u201315 (2010).","journal-title":"Diabetes Technol Ther."},{"issue":"2","key":"42555_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1055\/s-2006-923887","volume":"114","author":"D Deiss","year":"2006","unstructured":"Deiss, D., Hartmann, R., Schmidt, J. & Kordonouri, O. Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes. 114(2), 63\u20137 (2006).","journal-title":"Exp Clin Endocrinol Diabetes."},{"issue":"12","key":"42555_CR6","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.2337\/diacare.24.12.2030","volume":"24","author":"FR Kaufman","year":"2001","unstructured":"Kaufman, F. R. et al. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care. 24(12), 2030\u20134 (2001).","journal-title":"Diabetes Care."},{"issue":"2","key":"42555_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1542\/peds.107.2.222","volume":"107","author":"HP Chase","year":"2001","unstructured":"Chase, H. P. et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics. 107(2), 222\u20136 (2001).","journal-title":"Pediatrics."},{"key":"42555_CR8","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1542\/peds.111.5.933","volume":"111","author":"J Ludvigsson","year":"2003","unstructured":"Ludvigsson, J. & Hanas, R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics. 111, 933\u2013938 (2003).","journal-title":"Pediatrics."},{"issue":"3","key":"42555_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1399-543X.2006.00162.x","volume":"7","author":"WH Lagarde","year":"2006","unstructured":"Lagarde, W. H. et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes. 7(3), 159\u201364 (2006).","journal-title":"Pediatr Diabetes."},{"issue":"7","key":"42555_CR10","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2337\/dc05-2315","volume":"29","author":"K Yates","year":"2006","unstructured":"Yates, K., Hasnat, M. A., Dear, K. & Ambler, G. Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial. Diabetes Care. 29(7), 1512\u20137 (2006).","journal-title":"Diabetes Care."},{"key":"42555_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1758-5996-5-39","volume":"5","author":"N Poolsup","year":"2013","unstructured":"Poolsup, N., Suksomboon, N. & Kyaw, A. M. Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes. Diabetol Metab Syndr. 5, 39 (2013).","journal-title":"Diabetol Metab Syndr."},{"issue":"10","key":"42555_CR12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.20452\/pamw.1087","volume":"121","author":"P Wojciechowski","year":"2011","unstructured":"Wojciechowski, P., Ry\u015b, P., Lipowska, A., Gaw\u0119ska, M. & Ma\u0142ecki, M. T. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis. Pol Arch Med Wewn. 121(10), 333\u201343 (2011).","journal-title":"Pol Arch Med Wewn."},{"issue":"4","key":"42555_CR13","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1177\/193229681100500419","volume":"5","author":"GY Gandhi","year":"2011","unstructured":"Gandhi, G. Y. et al. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol. 5(4), 952\u201365 (2011).","journal-title":"J Diabetes Sci Technol."},{"key":"42555_CR14","unstructured":"Medtronic iPro2 CGM User Guide, https:\/\/www.medtronicdiabetes.com\/sites\/default\/files\/library\/download-library\/user-guides\/iPro2-with-Enlite-User-Guide.pdf. Accessed on May 21, 2017."},{"key":"42555_CR15","unstructured":"Medtronic CareLink iPro Therapy Management Software for Diabetes -user guide, https:\/\/www.medtronicdiabetes.com\/sites\/default\/files\/library\/download-library\/user guides\/CareLink_iPro2_User_Guide-en-US.pdf. Accessed on May 21, 2017."},{"issue":"1","key":"42555_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/152091500316737","volume":"2","author":"TM Gross","year":"2000","unstructured":"Gross, T. M. et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther. 2(1), 49\u201356 (2000).","journal-title":"Diabetes Technol Ther."},{"key":"42555_CR17","first-page":"751","volume":"12","author":"J Mastrototaro","year":"1999","unstructured":"Mastrototaro, J. The MiniMed Continuous Glucose Monitoring System (P-CGM). J Pediatr Endocrinol Metab. 12, 751\u2013758 (1999).","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"3 Pt 1","key":"42555_CR18","first-page":"E561","volume":"277","author":"K Rebrin","year":"1999","unstructured":"Rebrin, K., Steil, G. M., van Antwerp, W. P. & Mastrototaro, J. J. Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol. 277(3 Pt 1), E561\u201371 (1999).","journal-title":"Am J Physiol."},{"key":"42555_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2337\/diacare.16.5.695","volume":"16","author":"FJ Schmidt","year":"1993","unstructured":"Schmidt, F. J., Sluiter, W. J. & Schoonen, A. J. Glucose concentration in subcutaneous extracellular space. Diabetes Care. 16, 695\u2013700 (1993).","journal-title":"Diabetes Care."},{"issue":"9","key":"42555_CR20","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2337\/diacare.18.9.1266","volume":"18","author":"F Sternberg","year":"1995","unstructured":"Sternberg, F., Meyerhoff, C., Mennel, F. J., Bischof, F. & Pfeiffer, E. F. Subcutaneous glucose concentration in humans. Real estimation and continuous monitoring. Diabetes Care. 18(9), 1266\u20139 (1995).","journal-title":"Diabetes Care."},{"issue":"3","key":"42555_CR21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/1932296814528135","volume":"8","author":"LE Rasbach","year":"2014","unstructured":"Rasbach, L. E. et al. Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes. J Diabetes Sci Technol. 8(3), 494\u20137 (2014).","journal-title":"J Diabetes Sci Technol."},{"issue":"5","key":"42555_CR22","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1177\/193229681200600513","volume":"6","author":"B Floyd","year":"2012","unstructured":"Floyd, B. et al. Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus. J Diabetes Sci Technol. 6(5), 1094\u2013102 (2012).","journal-title":"J Diabetes Sci Technol."},{"key":"42555_CR23","unstructured":"Deke, J., Sama-Miller, E. & Hershey, A. Addressing Attrition Bias in Randomized Controlled Trials: Considerations for Systematic Evidence Reviews 2015. Available from, http:\/\/homvee.acf.hhs.gov\/HomVEE-Attrition-White_Paper-7-2015.pdf. Accessed on December 15 2015."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42555-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42555-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42555-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T23:13:25Z","timestamp":1721171605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42555-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42555"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42555-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,16]]},"assertion":[{"value":"29 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6120"}}